Also known as Doribax
Doripenem (common name doripenem monohydrate) is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa.Source: Wikipedia
Estimated Total Cost: $786.06 for an average of 7 days supply
Patients are most commonly prescribed doripenem to treat blastomycosis, rabies, west nile virus, and pick disease.